← Back to all trials
Recruiting
NCT07332546
EOIB for Pain After Laparoscopic Cholecystectomy
Conditions: Postoperative Pain, Laparoscopic Cholecystectomy
Sex: All
Ages: 18 Years – 85 Years
Healthy volunteers: No
Phase: NA
Enrollment: 56
Sponsor: Shiyou Wei
Location: Tianmen First People's Hospital Tianmen Hubei
Summary
This prospective, randomized, controlled, assessor-blinded trial will evaluate whether bilateral ultrasound-guided external oblique intercostal block (EOIB) reduces postoperative opioid consumption and improves pain control after laparoscopic cholecystectomy, compared with no block.
Eligibility Criteria
Inclusion Criteria:
* Aged 18-85 years, regardless of gender
* American Society of Anesthesiologists (ASA) physical status classification I-III
* Scheduled for elective laparoscopic cholecystectomy
* Ability to use the intravenous patient-controlled analgesia (IV PCA) system
Exclusion Criteria:
* Hepatic disease (e.g., liver enzyme levels ≥ 2× the upper limit of normal)
* Renal disease (e.g., serum creatinine levels ≥ 2× the upper limit of normal)
* Allergy or known hypersensitivity to local anesthetics
* Females who are pregnant or lactating
* Conversion to open surgery
* Coagulopathy or current use of anticoagulant medications
* Opioid use for more than 2 weeks in the past 6 months
Source: ClinicalTrials.gov (NCT07332546). StuddyBuddy aggregates publicly available trial information.